410 related articles for article (PubMed ID: 27454452)
1. Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation.
Yamashita S; Matsuzawa Y
Curr Opin Lipidol; 2016 Oct; 27(5):459-72. PubMed ID: 27454452
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer protein (CETP) deficiency and CETP inhibitors.
Mabuchi H; Nohara A; Inazu A
Mol Cells; 2014 Nov; 37(11):777-84. PubMed ID: 25410905
[TBL] [Abstract][Full Text] [Related]
3. Future of cholesteryl ester transfer protein (CETP) inhibitors: a pharmacological perspective.
Mohammadpour AH; Akhlaghi F
Clin Pharmacokinet; 2013 Aug; 52(8):615-26. PubMed ID: 23658137
[TBL] [Abstract][Full Text] [Related]
4. Restoration of high-density lipoprotein levels by cholesteryl ester transfer protein expression in scavenger receptor class B type I (SR-BI) knockout mice does not normalize pathologies associated with SR-BI deficiency.
Hildebrand RB; Lammers B; Meurs I; Korporaal SJ; De Haan W; Zhao Y; Kruijt JK; Praticò D; Schimmel AW; Holleboom AG; Hoekstra M; Kuivenhoven JA; Van Berkel TJ; Rensen PC; Van Eck M
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1439-45. PubMed ID: 20431066
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Cholesteryl Ester Transfer Protein Protects Against Atherosclerosis in Rabbits.
Zhang J; Niimi M; Yang D; Liang J; Xu J; Kimura T; Mathew AV; Guo Y; Fan Y; Zhu T; Song J; Ackermann R; Koike Y; Schwendeman A; Lai L; Pennathur S; Garcia-Barrio M; Fan J; Chen YE
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1068-1075. PubMed ID: 28428219
[TBL] [Abstract][Full Text] [Related]
6. On- and off-target pharmacology of torcetrapib: current understanding and implications for the structure activity relationships (SAR), discovery and development of cholesteryl ester-transfer protein (CETP) inhibitors.
Johns DG; Duffy J; Fisher T; Hubbard BK; Forrest MJ
Drugs; 2012 Mar; 72(4):491-507. PubMed ID: 22356288
[TBL] [Abstract][Full Text] [Related]
7. Cholesteryl ester transfer protein (CETP) expression enhances HDL cholesteryl ester liver delivery, which is independent of scavenger receptor BI, LDL receptor related protein and possibly LDL receptor.
Zhou H; Li Z; Silver DL; Jiang XC
Biochim Biophys Acta; 2006 Dec; 1761(12):1482-8. PubMed ID: 17055779
[TBL] [Abstract][Full Text] [Related]
8. Future of cholesteryl ester transfer protein inhibitors.
Rader DJ; deGoma EM
Annu Rev Med; 2014; 65():385-403. PubMed ID: 24422575
[TBL] [Abstract][Full Text] [Related]
9. Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.
Kappelle PJ; van Tol A; Wolffenbuttel BH; Dullaart RP
Cardiovasc Ther; 2011 Dec; 29(6):e89-99. PubMed ID: 20645987
[TBL] [Abstract][Full Text] [Related]
10. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.
Niesor EJ
Curr Opin Lipidol; 2011 Aug; 22(4):288-95. PubMed ID: 21587074
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role of CETP in HDL remodeling and cholesterol efflux: role of cysteine 13 of CETP.
Maugeais C; Perez A; von der Mark E; Magg C; Pflieger P; Niesor EJ
Biochim Biophys Acta; 2013 Nov; 1831(11):1644-50. PubMed ID: 23872476
[TBL] [Abstract][Full Text] [Related]
12. Structure-based mechanism and inhibition of cholesteryl ester transfer protein.
Xue H; Zhang M; Liu J; Wang J; Ren G
Curr Atheroscler Rep; 2023 Apr; 25(4):155-166. PubMed ID: 36881278
[TBL] [Abstract][Full Text] [Related]
13. Roles of plasma lipid transfer proteins in reverse cholesterol transport.
Yamashita S; Sakai N; Hirano K; Ishigami M; Maruyama T; Nakajima N; Matsuzawa Y
Front Biosci; 2001 Mar; 6():D366-87. PubMed ID: 11229884
[TBL] [Abstract][Full Text] [Related]
14. [Advances on the research of the relationship between cholesteryl ester transfer protein and atherosclerosis].
Huang ZY; Guo HW
Wei Sheng Yan Jiu; 2005 Nov; 34(6):765-7. PubMed ID: 16535859
[TBL] [Abstract][Full Text] [Related]
15. Cholesteryl ester transfer protein and its inhibition.
Weber O; Bischoff H; Schmeck C; Böttcher MF
Cell Mol Life Sci; 2010 Sep; 67(18):3139-49. PubMed ID: 20556633
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?
Schaefer EJ
Curr Opin Lipidol; 2013 Jun; 24(3):259-64. PubMed ID: 23652567
[TBL] [Abstract][Full Text] [Related]
17. Investigational CETP antagonists for hyperlipidemia and atherosclerosis prevention.
Sirtori CR
Expert Opin Investig Drugs; 2011 Nov; 20(11):1543-54. PubMed ID: 21961529
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl Ester Transfer Protein Inhibition for Preventing Cardiovascular Events: JACC Review Topic of the Week.
Armitage J; Holmes MV; Preiss D
J Am Coll Cardiol; 2019 Feb; 73(4):477-487. PubMed ID: 30704580
[TBL] [Abstract][Full Text] [Related]
19. Aerobic exercise improves reverse cholesterol transport in cholesteryl ester transfer protein transgenic mice.
Rocco DD; Okuda LS; Pinto RS; Ferreira FD; Kubo SK; Nakandakare ER; Quintão EC; Catanozi S; Passarelli M
Lipids; 2011 Jul; 46(7):617-25. PubMed ID: 21479674
[TBL] [Abstract][Full Text] [Related]
20. Cholesteryl ester transfer protein (CETP) inhibitors.
Hunt JA; Lu Z
Curr Top Med Chem; 2009; 9(5):419-27. PubMed ID: 19519458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
